HUMAN cDNA SEQUENCE PATENTABILITY PUBLIC DISCUSSIONS
Executive Summary
HUMAN cDNA SEQUENCE PATENTABILITY PUBLIC DISCUSSIONS may be promoted by NIH as a follow up to its formal decision to abandon all U.S. patent applications for gene fragments identified in NIH labs. In a Feb. 11 statement, NIH recognized that "although it is no longer pursuing patent applications relating to cDNA sequences, it is possible that others -- in academia or private industry -- are. NIH believes it would be useful to continue the public dialogue on this subject and would participate in or facilitate such discussions."